Bill Gates the co-founder of Microsoft has been actively involved in investing for change to lessen the impact of climate change. Gates is doing this by investing in companies such as Quantumscape (NYSE: QS), whose objective is to develop solid state batteries for electric vehicles.
September 29, 12:30 PM
When Carl Icahn buys shares of stock, it's what is known as the “Icahn lift." This refers to the impact that the so-called "corporate raider" has on purchasing shares of an underlying company.
He Bet Against Subprime Mortgages, Now John Paulson Is Bullish On Gold Stocks: 2 Gold Mining High Yielders He Owns
September 28, 11:22 AM
A Wall Street investor, who's his claim to fame was betting against subprime mortgages by using credit default swaps, appears to be bullish on equities in the gold sector.
September 27, 2:14 PM
Along with other large banks, Goldman Sachs Group Inc (NYSE: GS) is becoming less bullish on stocks in the near term, saying that markets have not yet factored in the possibility of a worldwide recession.
September 27, 11:55 AM
On Monday, Dan Niles, the founder of the Satori Fund, joined CNBC’s ‘Squawk Box’ to discuss the current condition of the market.
September 23, 12:44 PM
Trian Partners was founded in 2005 by activist investor Nelson Peltz, who has a history of buying up shares, securing board seats and orchestrating M&A deals.
September 15, 1:40 PM
The Federal Reserve's raising of interest rates could bring the economy "down," according to billionaire Ray Dalio. In a recent LinkedIn post, the Bridgewater Associates founder said increasing interest rates to about 4.5% — meant to offset inflation — will cause stock prices to plummet by 20%.
September 13, 4:58 PM
Conformis (NASDAQ: CFMS) has received 510(k) clearance from the U.S. Food and Drug Administration for its Actera Hip System. Actera utilizes an advanced tri-taper femur stem design that facilitates direct anterior approach total hip arthroplasties, and provides an additional stem option to orthopedic surgeons.
September 13, 4:23 PM
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Syros Pharmaceuticals (NASDAQ: SYRS) lead candidate SY-5609 for the treatment of pancreatic cancer.
September 13, 6:08 AM
Talks regarding KKR & Co (NYSE:KKR)-led consortium buying Australian hospital operator Ramsay Health Care Ltd (OTC:RMSYF) (OTC:RMYHY) have hit a snag. The consortium…